3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023

3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial enrol

Related Keywords

South Africa ,United States ,Tennessee ,Chattanooga ,Americans ,American ,Craig Humphreys ,Scott Hodges ,Jeffreya Goldstein ,Marc Peterman ,Linkedin ,Facebook ,Medtronic ,Spine Inc ,American Medical Association ,Premarket Approval ,Breakthrough Device ,Device Exemption ,Principal Investigator ,American Board ,Spine Surgery ,Total Joint Replacement ,